PMID- 15569671 OWN - NLM STAT- MEDLINE DCOM- 20050322 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 280 IP - 5 DP - 2005 Feb 4 TI - Hydrogen peroxide potentiates volume-sensitive excitatory amino acid release via a mechanism involving Ca2+/calmodulin-dependent protein kinase II. PG - 3548-54 AB - Excessive excitatory amino acid (EAA) release in cerebral ischemia is a major mechanism responsible for neuronal damage and death. A substantial fraction of ischemic EAA release occurs via volume-regulated anion channels (VRACs). Hydrogen peroxide (H2O2), which is abundantly produced during ischemia and reperfusion, activates a number of protein kinases critical for VRAC functioning and has recently been reported to activate VRACs. In the present study, we explored the effects of H2O2 on volume-dependent EAA release in cultured astrocytes, measured as the release of preloaded D-[3H]aspartate. 100-1,000 microm H2O2 enhanced swelling-induced EAA release by approximately 2.5-3-fold (EC50 approximately 10 microM). The VRAC blockers ATP, phloretin, and 5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB) potently inhibited both control swelling-induced and the H2O2-potentiated release, suggesting a role for VRACs. The H2O2-induced component of EAA release was attenuated by the Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester (BAPTA-AM) and completely eliminated by the calmodulin antagonists trifluoperazine and W-7 and the Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor KN-93. Inhibitors of tyrosine kinases, protein kinase C, and the myosin light chain kinase were ineffective in blocking the H2O2 response. H2O2 treatment of swollen astrocytes, but not swelling alone, resulted in CaMKII activation that was inhibited by KN-93, as determined by a phospho-Thr286 CaMKII antibody. These data demonstrate that H2O2 strongly up-regulates astrocytic volume-sensitive EAA release via a CaMKII-dependent mechanism and in this way may potently promote pathological EAA release and brain damage in ischemia. FAU - Haskew-Layton, Renee E AU - Haskew-Layton RE AD - Center for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York 12208, USA. FAU - Mongin, Alexander A AU - Mongin AA FAU - Kimelberg, Harold K AU - Kimelberg HK LA - eng GR - F31 NS046961/NS/NINDS NIH HHS/United States GR - R01 NS035205/NS/NINDS NIH HHS/United States GR - F31-NS46961/NS/NINDS NIH HHS/United States GR - R01-NS35205/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. DEP - 20041129 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Amino Acids) RN - 0 (Anions) RN - 0 (Ion Channels) RN - 0 (Oxidants) RN - 10028-17-8 (Tritium) RN - 30KYC7MIAI (Aspartic Acid) RN - 3KX376GY7L (Glutamic Acid) RN - BBX060AN9V (Hydrogen Peroxide) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinase Type 2) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases) SB - IM MH - Amino Acids/*metabolism MH - Animals MH - Anions/metabolism MH - Aspartic Acid/pharmacokinetics MH - Astrocytes/cytology/drug effects/*metabolism MH - Calcium-Calmodulin-Dependent Protein Kinase Type 2 MH - Calcium-Calmodulin-Dependent Protein Kinases/*metabolism MH - Cells, Cultured MH - Glutamic Acid/pharmacokinetics MH - Hydrogen Peroxide/*pharmacology MH - Ion Channels/metabolism MH - Oxidants/*pharmacology MH - Rats MH - Rats, Sprague-Dawley MH - Signal Transduction/drug effects/physiology MH - Tritium EDAT- 2004/12/01 09:00 MHDA- 2005/03/23 09:00 CRDT- 2004/12/01 09:00 PHST- 2004/12/01 09:00 [pubmed] PHST- 2005/03/23 09:00 [medline] PHST- 2004/12/01 09:00 [entrez] AID - S0021-9258(20)76222-8 [pii] AID - 10.1074/jbc.M409803200 [doi] PST - ppublish SO - J Biol Chem. 2005 Feb 4;280(5):3548-54. doi: 10.1074/jbc.M409803200. Epub 2004 Nov 29.